Cadence Capital Management’s STAAR Surgical STAA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-20,571
Closed -$664K 447
2020
Q1
$664K Sell
20,571
-59,592
-74% -$2.01M 0.11% 276
2019
Q4
$2.82M Sell
80,163
-8,107
-9% -$267K 0.3% 69
2019
Q3
$2.28M Sell
88,270
-21,469
-20% -$652K 0.32% 114
2019
Q2
$3.22M Sell
109,739
-3,671
-3% -$106K 0.32% 68
2019
Q1
$3.88M Buy
113,410
+45,387
+67% +$1.61M 0.35% 64
2018
Q4
$2.17M Buy
+68,023
New +$2.65M 0.22% 137

Other funds holding STAA

Cadence Capital Management's STAA Position: Q2 2020 in Review

Cadence Capital Management sold out of STAAR Surgical (STAA) in Q2 2020, closing a stake of 20,571 shares — an estimated $664K sold.

Cadence Capital Management first reported a position in STAA in Q4 2018 and held it in 6 quarters. The position peaked at $3.88M in Q1 2019. 193 funds tracked by Wall St. Rank hold STAA as of Q2 2020.

  • Cadence Capital Management reported no remaining STAAR Surgical position as of Q2 2020 after selling out during the quarter.
  • Cadence Capital Management sold 20,571 STAAR Surgical shares in Q2 2020, an estimated $664K.
  • Cadence Capital Management first reported a position in STAAR Surgical in Q4 2018 and held it in 6 quarters.
  • Cadence Capital Management's STAAR Surgical position peaked at $3.88M in Q1 2019.
  • 193 funds tracked by Wall St. Rank held STAAR Surgical as of Q2 2020.

Based on Cadence Capital Management's 13F filing for Q2 2020, filed 3 Aug 2020.